Moneycontrol PRO
HomeNewsPlethico pharma

Plethico Pharma

Jump to
  • Plethico Pharma consolidated Dec '14 sales at Rs 111.45 crore

    Plethico Pharmaceuticals has reported a consolidated total income from operations of Rs 111.45 crore and a net loss of Rs 4.07 crore for the quarter ended Dec '14

  • Plethico Pharma consolidated Dec '13 sales at Rs 364.38 crore

    Plethico Pharma consolidated Dec '13 sales at Rs 364.38 crore

    Plethico Pharmaceuticals has reported a sales turnover of Rs 364.38 crore and a net profit of Rs 44.07 crore for the quarter ended Dec '13

  • Stocks in news: Cairn India, Elder Pharma, Ambuja, Bharti

    Stocks in news: Cairn India, Elder Pharma, Ambuja, Bharti

    Cairn India | Elder Pharma | Tata Power | Ambuja Cements | Financial Technologies | MCX India | Bharti Airtel | Idea Cellular and Reliance Communications are stocks, which are in the news today.

  • Plethico Pharma consolidated Sep '13 sales at Rs 470.69 crore

    Plethico Pharma consolidated Sep '13 sales at Rs 470.69 crore

    Plethico Pharmaceuticals has reported a sales turnover of Rs 470.69 crore and a net profit of Rs 20.97 crore for the quarter ended Sep '13

  • Here's how small cap stocks open on August 27

    Here's how small cap stocks open on August 27

    Here's how small cap stocks open on August 27

  • Plethico Pharma consolidated Jun '13 sales at Rs 518.21 crore

    Plethico Pharma consolidated Jun '13 sales at Rs 518.21 crore

    Plethico Pharmaceuticals has reported a sales turnover of Rs 518.21 crore and a net profit of Rs 44.40 crore for the quarter ended Jun '13

  • Plethico Pharma consolidated Mar '13 sales at Rs 490.50 crore

    Plethico Pharma consolidated Mar '13 sales at Rs 490.50 crore

    Plethico Pharmaceuticals has reported a sales turnover of Rs 490.50 crore and a net profit of Rs 13.23 crore for the quarter ended Mar '13

  • Bull's eye: Buy Shriram Transport, Wockhardt; short HDIL

    Bull's eye: Buy Shriram Transport, Wockhardt; short HDIL

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Hexaware Tech, Plethico Pharma, Jai Corp: Tulsian

    Buy Hexaware Tech, Plethico Pharma, Jai Corp: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

  • Bull's eye: Buy Hexaware, AB Nuvo, Jai Corp; short Titan

    Bull's eye: Buy Hexaware, AB Nuvo, Jai Corp; short Titan

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's eye: Buy PNB Gilts, Unitech, Century; short RComm

    Bull's eye: Buy PNB Gilts, Unitech, Century; short RComm

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's eye: Buy TVS Motor, Suzlon, CMC, short Infosys

    Bull's eye: Buy TVS Motor, Suzlon, CMC, short Infosys

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's eye: Buy Suzlon Energy, SPIC, short SAIL, HDIL

    Bull's eye: Buy Suzlon Energy, SPIC, short SAIL, HDIL

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Plethico Pharma, Shasun Pharma: Tulsian

    Buy Plethico Pharma, Shasun Pharma: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

  • Buy Plethico Pharma, West Coast Paper, Sintex: Tulsian

    Buy Plethico Pharma, West Coast Paper, Sintex: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

  • Buy Shree Renuka, Plethico Pharma, Ind-Swift Labs: Tulsian

    Buy Shree Renuka, Plethico Pharma, Ind-Swift Labs: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

  • Plethico Pharma Q4 cons PAT down 23% at Rs 55 cr

    Plethico Pharma Q4 cons PAT down 23% at Rs 55 cr

    Plethico Pharma has announced its foruth quarter results. The company's Q4FY11 consolidated revenues were up 5.4% at Rs 354 crore versus Rs 336 crore.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347